CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 28, 2012--
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the
Seventh Annual JMP Securities Healthcare Conference on July 12, 2012, at
9:00 a.m. ET in New York City.
A live webcast of Infinity's presentation will be accessible on the
“investors/media” section of the company's website, www.infi.com,
and will be available for 30 days following the event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative drug discovery and development company seeking
to discover, develop and deliver to patients best-in-class medicines for
diseases with significant unmet need. Infinity combines proven
scientific expertise with a passion for developing novel small molecule
drugs that target emerging disease pathways. Infinity’s programs focused
on the inhibition of heat shock protein 90 and phosphoinositide-3-kinase
are evidence of its innovative approach to drug discovery and
development. For more information on Infinity, please refer to the
company’s website at www.infi.com.
Source: Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc.
Jaren Irene Madden,
617-453-1336
Jaren.Madden@infi.com
http://www.infi.com
